Volume 20, Number 2—February 2014
Nasopharyngeal Bacterial Interactions in Children
Highlight and copy the desired format.
|EID||Almudevar A. Nasopharyngeal Bacterial Interactions in Children. Emerg Infect Dis. 2014;20(2):339-340. https://dx.doi.org/10.3201/eid2002.131701|
|AMA||Almudevar A. Nasopharyngeal Bacterial Interactions in Children. Emerging Infectious Diseases. 2014;20(2):339-340. doi:10.3201/eid2002.131701.|
|APA||Almudevar, A. (2014). Nasopharyngeal Bacterial Interactions in Children. Emerging Infectious Diseases, 20(2), 339-340. https://dx.doi.org/10.3201/eid2002.131701.|
In Response: The point made by Suzuki et al. (1) is an interesting one, but it is not directly relevant to our conclusions (2). To summarize, given bacterium 1 and bacterium 2, suppose OR[pop] is the odds ratio (OR) between bacterium 1 and bacterium 2 in the population. If r[c] and r[n] are the risk of enrollment among colonization-positive and colonization-negative children, respectively, then OR[case] = (r[n]/r[c])OR[pop], so that OR[case] <1 can be attributed to a higher risk among colonized children.
The underlying assumption of the analysis is that enrollment risk is constant for both bacteria (alone or in combination). In fact, differential risk does exist, and it cannot be separated from the issue of the relative aggressiveness of the bacterium. This can be seen by considering the ORs in the Table.
When we compared the ORs between bacteria pairs for all subjects and children with acute otitis media (AOM), we found a large decrease for pairs involving nontypeable Haemophilus influenzae (NTHi), in contrast to the remaining pair, Streptococcus pneumoniae/ Moraxella catarrhailis (Spn/Mcat). We do not believe that these values are explainable by the effect described by Suzuki et al., especially when (as is done in that analysis) we assume a colonization-positive risk of enrollment r[c] that is independent of bacterium distribution. We also point out that these estimates are instructive, but not sufficient, because each pairwise comparison may depend on interactions with the third bacterium. We therefore used a statistical model (2,3) that permits the isolation of third-order effects by modeling co-occurrence rates of 2 bacteria while controlling for a third. This allowed us to reach our conclusion, which is primarily concerned with the specific role played by NTHi, and follows from the existence of a pattern in the reported ORs, rather than the absolute value of any single OR.
It is also instructive to examine the colonization rates for AOM versus number of AOM events (nAOM) subjects: p(Spn-nAOM) = 0.30; p(Spn-AOM) = 0.53; p(NTHi-nAOM) = 0.12; p(NTHi-AOM) = 0.48; p(Mcat -nAOM) = 0.36; p(Mcat-AOM) = 0.43. As we would expect, colonization rates of each bacterium are higher for AOM patients. What is of interest is that the colonization distribution is different for children with AOM, which suggests that NTHi is more aggressive than other bacteria in some sense, and this effect is made more precise by the statistical model we used. The essential point is that the issue of competitive association cannot be isolated from differential enrollment risks, which is what our analysis reports.
- Suzuki M, Dhoubhadel BG, Yoshida LM, Ariyoshi K. Nasopharyngeal bacterial interactions in children [letter] [Internet]. Emerg Infect Dis. 2014;20:323–4 .
- Xu Q, Almudervar A, Casey JR, Pichichero ME. Nasopharyngeal bacterial interactions in children. Emerg Infect Dis. 2012;18:1738–45 and.
- Pettigrew MM, Gent JF, Revai K, Patel JA, Chonmaitree T. Microbial interactions during upper respiratory tract infections. Emerg Infect Dis. 2008;14:1584–91 and.
- Table. Comparison of the odds ratios between bacterium pairs for all subjects and children with acute otitis media
1On behalf of Qingfu Xu Janet Casey, and Michael Pichichero.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: January 08, 2014
- Page last updated: January 08, 2014
- Page last reviewed: January 08, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)